Bracebridge Capital

Bracebridge Capital is a Boston-based alternative asset manager and SEC-registered investment adviser that manages absolute return investment strategies for a diversified institutional and high-net-worth investor base. The firm focuses primarily on global fixed income, credit, derivatives, and other opportunistic investment strategies rather than developing therapeutic products. While it has participated in healthcare and biopharma-focused investing activities, including credit and royalty opportunities, Bracebridge Capital is not itself a biotechnology, pharmaceutical, or healthcare operating company. It is best characterized as a financial services firm with exposure to life sciences investing rather than a life sciences issuer.